Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

UV rays can cause a type of hair loss known as telogen alopecia.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Lactobacillus paracasei HY7015 helps hair grow in mice.

CARI ONE helps start hair growth and makes hair follicles bigger and more numerous.

Emodin may help hair grow similarly to minoxidil and could treat baldness.

Cosmetic foam product reduces hair loss and increases hair density in men.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Hair loss in women can improve with iron and vitamin supplements if caused by iron deficiency.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

COVID-19 may cause a common type of hair loss called telogen effluvium.

A 532 nm laser at 15 J/cm2 speeds up tendon healing by increasing tendon stem cell growth and tendon-related gene activity.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Hair loss causes stress and affects mental health; treatment and support needed.

Hair stops producing melanin as it transitions from the growth phase to the resting phase.

Estrogen affects hair growth and skin cell multiplication.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Tiny particles from stem cells help activate hair growth cells and encourage hair growth in mice without being toxic.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document says there are five types of hair loss conditions and different causes, including drugs.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.